The authors reply
主要な著者: | Chapman, D, Judge, PK, Arnold, T, Staplin, N, Clark, S, Haynes, R, Moffat, S, Herrington, WG, Hill, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2023
|
類似資料
-
Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study
著者:: Judge, PK, 等
出版事項: (2023) -
Allocated but not treated: the silent 16% – Authors' reply
著者:: Horby, P, 等
出版事項: (2022) -
Authors' reply
著者:: Herrington, W, 等
出版事項: (2018) -
Impact of primary kidney disease on the effects of empagliflozin in patients with CKD
著者:: Judge, PK, 等
出版事項: (2023) -
The prevention and management of chronic kidney disease among patients with metabolic syndrome
著者:: Zhu, D, 等
出版事項: (2025)